• Technology
  • DuplexSeq™ Kits
    • AML Assay
    • Mutagenesis Assay
    • Custom
  • Resources
    • Publications
    • Posters
    • Safety
    • Patents
  • Company
    • Our Team
    • Careers
    • Events
    • News
    • Investors
  • Contact

Meet with TwinStrand at the SOT 2023 Annual Meeting in Nashville, TN
Presentation: 9:00 AM, 3/22, Room 101C | Posters: 3604, 3606, 3244

Schedule a Meeting
TwinStrand Biosciences
  • Technology
  • DuplexSeq™ Kits
    • AML Assay
    • Mutagenesis Assay
    • Custom
  • Resources
    • Publications
    • Posters
    • Safety
    • Patents
  • Company
    • Our Team
    • Careers
    • Events
    • News
    • Investors
  • Contact

 

In the News

 

Business Wire - October 13, 2022
TwinStrand Biosciences Announces Leadership Transition

TwinStrand Biosciences has announced that the company has implemented a reorganization designed to sustain growth through a focus on key commercial initiatives. As part of this effort, TwinStrand has named Chad Brown as interim Chief Executive Officer, while TwinStrand founder, Jesse Salk, MD, PhD, will continue to serve the company as Chief Scientific Officer.

READ MORE
X
TwinStrand Biosciences Announces Leadership Transition
Business Wire - October 13, 2022
TwinStrand Biosciences Announces Leadership Transition
READ MORE
Globe Newswire - June 06, 2022
Singular Genomics and TwinStrand Biosciences Collaborate to Develop Ultra-high Accuracy NGS Solutions for the G4 Platform
READ MORE
Business Wire - June 06, 2022
TwinStrand Biosciences to Showcase Recent Applications of its Duplex Sequencing Technology at the 2022 AGBT Annual Meeting
READ MORE
Life Science Washington - April 20, 2022
Life Science Innovation Northwest 2022

Our CEO, Jesse Salk MD, PhD will be speaking at the Life Sciences Innovation Northwest (LSINW) 2022 Convention during the Research Tools & Medical Device session.
 
Wednesday, April 20th, 2022 – 2:46pm PST

LEARN MORE
Inside Precision News - April 12, 2022
How Duplex Sequencing Can Improve MRD Detection:
An Interview with Jesse Salk, MD, PhD, CEO of TwinStrand Biosciences
READ THE INTERVIEW
TwinStrand Biosciences - February 24, 2022
National Firefighter Cancer Symposium 2022

This year we were proud to sponsor the scientific workshop Applying Molecular Biology & Genetic Toxicology Methods to Improve Risk Assessment and Guide Risk Management Decisions for Cancer in Firefighters at the 2022 National Cancer Fire Symposium, hosted by the Firefighter Cancer Initiative (FCI).

WATCH THE VIDEO
FNIH - February 11, 2022
TwinStrand partners with the FNIH in Project for Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML)

TwinStrand Biosciences, Inc. was selected to join the FNIH Biomarkers Consortium Project aiming to establish new methods for detecting measurable residual disease (MRD) in Acute Myeloid Leukemia (AML). See the FNIH announcement here.

Read More
TwinStrand Biosciences - August 3, 2021
TwinStrand Biosciences Announces Filing of Patent Infringement Lawsuit Against Guardant Health
Read More
Business Wire - May 6, 2021
TwinStrand Biosciences Announces $50 Million Series B to Expand the Adoption of its Duplex Sequencing Technology in Applications Requiring the Highest Sensitivity and Accuracy
Read More
GenomeWeb - January 6, 2021
TwinStrand Biosciences Explores Error Reduction Sequencing Tech in Various Applications
Read More
PRNewswire - December 15, 2020
TwinStrand Biosciences Announces Peer-Reviewed Publication of Study Results Highlighting Ability of Duplex Sequencing Technology to Rapidly Detect the Mutagenic Activity of Chemicals
Read More
PRNewswire - November 18, 2020
TwinStrand Biosciences Licenses Duplex Sequencing Technology to Foundation Medicine
Read More
Puget Sound Business Journal - October 1, 2020
40 Under 40: Jesse Salk diagnoses cancer using DNA sequencing and treats the disease as a practicing oncologist
Read More
GEN - August 1, 2020
Liquid Biopsies Generate Ample Insights from Sparse Clues
Read More
Gene Online - July 20, 2020
The Profound Impact of Duplex Sequencing: An Interview with Jesse Salk, CEO, TwinStrand Biosciences
Read More
Bio-IT World - July 15, 2020
In The Midst Of A Pandemic, Duplex Sequencing Comes Of Age
Read More
Timmerman Report - June 15, 2020
Timmerman Report- DNA Sequencing Startups Aim to Reduce Cost, Increase Meaning in the Data
Read More
GEN - April 1, 2020
Sequencing’s Stars Urge Exploration of New Dimensions
READ MORE
GEN - March 1, 2020
Genomic Medicine Identifies Reconcilable Differences
Read More
DeciBio - February 27, 2020
AGBT 2020: DeciBio Highlights – Spatial Profiling Reloaded & MGI Unleashed 2
Read More
PRNewswire - February 25, 2020
TwinStrand Biosciences Launches Duplex Sequencing Technology
Read More
GeekWire - January 7, 2020
TwinStrand raises $16M from Madrona and others for next-gen DNA sequencing, promising early cancer detection and other breakthroughs
Read More
LinkedIn - January 7, 2020
Leveraging big data to improve genome sequencing accuracy by 10,000x
Read More

 

TwinStrand Biosciences, Inc.
3131 Elliott Ave, Suite 750 • Seattle, WA 98121 • USA
+1 (877) 202-TWIN

 

For Research Use Only. Not for use in diagnostic procedures.

©2023 TwinStrand Biosciences, Inc. All rights reserved. All trademarks are the property of TwinStrand Biosciences, Inc. or their respective owners.  Legal Notices

  




American Society of Hematology (ASH)

December 5-8, 2020 – Virtual

 

Poster Presentation

 

“Duplex Sequencing with Patient-Specific Hybrid Capture Panels Reveals Ultra-Low Frequency Measurable Residual Disease in Pediatric Acute Myeloid Leukemia”

 

Presented by Jake Higgins, Senior Scientist – December 6, 2020 7:00 a.m.-3:30 p.m. PST

 

Conference Website

 

Society of Toxicology (SOT)

March 10-14, 2019 – Baltimore, MD

 

Poster Presentations

 

 

View Poster

 

 

Conference Website

 

AACR Annual Meeting – San Diego, CA

March 29-April 3, 2019

 

Poster Presentations

 

 

View Poster

 

 

View Poster

Presentations by CEO Jesse Salk, MD, PhD – AGBT 2020

Ultra-Sensitive Residual Leukemia Detection with Patient-Specific Dupex Sequencing